Compare · BJDX vs DHR

BJDX vs DHR

Side-by-side comparison of Bluejay Diagnostics Inc. (BJDX) and Danaher Corporation (DHR): market cap, price performance, sector, and recent activity on the wire.

Summary

  • BJDX operates in Health Care, while DHR operates in Industrials - the two are in different parts of the market.
  • DHR is the larger of the two at $163.93B, about 56230.2x BJDX ($2.9M).
  • DHR has been more active in the news (18 items in the past 4 weeks vs 6 for BJDX).
  • DHR has more recent analyst coverage (25 ratings vs 1 for BJDX).
MetricBJDXDHR
Company
Bluejay Diagnostics Inc.
Danaher Corporation
Price
-
-
Market cap
$2.9M
$163.93B
1M return
-
+0.67%
1Y return
-
+5.33%
Industry
Medical/Dental Instruments
Industrial Machinery/Components
Exchange
NASDAQ
NYSE
IPO
2021
News (4w)
6
18
Recent ratings
1
25
BJDX

Bluejay Diagnostics Inc.

Bluejay Diagnostics, Inc., an in-vitro diagnostic company, develops, manufactures, and markets minimally invasive point-of-care (POC) diagnostics tests and devices for infectious disease, inflammation, and oncology markets in the United States. It is developing Symphony biomarker detection platform for the detection of sepsis, cancer, cardiac ishcemia, and congestive heart failure. The company also offers ALLEREYE diagnostic test, a POC device for the diagnosis of allergic conjunctivitis. It has a collaboration agreement with Toray Industries, Inc. to develop a point of care test for covid-19 patient triage; and a research and development agreement with Naval Medical Research Center to develop lateral flow rapid test for diagnosis of various tick-borne diseases, including Lyme disease. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts.

DHR

Danaher Corporation

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology and molecular diagnostics products. This segment offers analytical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.

Latest BJDX

Latest DHR